Abstract
Three new thiazol derivatives of sulfanilamide have been studied with respect to their bacteriostatic action upon microorganisms. These compounds were found to be superior to sulfanilamide and sulfapyridine in their inhibitory actions upon pneumo-cocci Types I, II and III and beta Streptococcus hemolyticus Group A in concentrations as low as 5 mg %. Concentrations of 1 mg % proved the new derivatives to be more effective against the gono-coccus than the parent compound and sulfapyridine. The methyl and phenyl derivatives were found to be markedly bacteriostatic for Staphylococcus aureus. Sulfanilamide and sulfapyridine exhibited a moderate degree of inhibition upon the latter organism.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
